Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Gene therapy shows promise in model of Parkinson’s disease

30.11.2004


Scientists at the Ecole Polytechnique Federale de Lausanne (EPFL), Switzerland, have conducted novel experiments that might one day lead to gene therapy treatment options for patients with Parkinson’s disease.



In research published this week in the Proceedings of the National Academy of Sciences, the research team, led by EPFL President Patrick Aebischer, found that viral delivery of a gene associated with Parkinson’s disease protected neurons from degeneration.

Parkinson’s disease is a progressive, degenerative neurological disorder in which dopamine-producing neurons in the part of the brain responsible for coordinating muscle movement die or become so damaged that they are no longer able to function. Dopamine is a neurotransmitter, a "chemical messenger" that transfers information from neuron to neuron, ultimately allowing us to use our muscles in a smooth, coordinated way. Disease symptoms, such as tremor, rigidity, difficulty coordinating movement and difficulty with balance begin to manifest themselves when about 80% of a victim’s dopamine-producing neurons have died.


Scientists estimate that Parkinson’s disease affects 1-3 % of people over the age of 60. In the United States alone, 1.5 million people suffer from Parkinson’s disease, and about 60,000 new patients are diagnosed every year. Although it is commonly thought of as a disease of the elderly, 15% of Parkinson’s victims are under the age of 50.

Scientists are not sure what causes Parkinson’s disease. There is no way to prevent its onset and once diagnosed, it has no cure. Treatment is limited to ameliorating symptoms with a variety of therapies, including dopamine-based drug therapy. Only about 5-10 % of Parkinson’s appears to be inherited, and to date five genes have been implicated in patients with a familial history of the disease. Studies of these inherited forms of Parkinson’s have led to insights on its pathogenesis in sporadic or non-inherited cases.

One form of inherited Parkinson’s is associated with mutations in the alpha-synuclein gene that cause overexpression of the alpha-synuclein protein. Alpha-synuclein, in turn, is a major component of the proteinaceous intracellular deposits known as Lewy bodies that are characteristic of sporadic Parkinson’s. This suggests that the disease might be linked to a toxic overaccumulation of alpha-synuclein.

A more common, recessive form of inherited Parkinson’s disease typically strikes before the age of 40 and is linked to a mutation in the parkin gene. The loss of enzyme activity resulting from this mutation leads to an accumulation of protein substrates, including alpha-synuclein, in the cell. In these juvenile Parkinson’s cases Lewy bodies are not generally present.

Both these forms of the disease involve buildup of alpha-synuclein in the cell, and result in cell degeneration and death. All the evidence pointed to the possibility that parkin might play an important role in protecting neurons from toxic overaccumulations of alpha-synuclein. Aebischer, PhD student Christophe Lo Bianco and their colleagues tested this by injecting rats sub-cranially with lentiviral vectors containing the genes for parkin as well as a mutated form of the alpha-synuclein gene. Harmless forms of viruses such as the lentiviral vector are used by researchers because they can efficiently penetrate cells and deliver the gene of interest without inducing a major immune response.

The viruses successfully delivered the genetic material to about 30% of the rat neurons, causing overexpression of parkin and alpha-synuclein. After six weeks, the researchers found that almost all these affected dopamine neurons in rats that had been injected with alpha-synuclein alone had died. In contrast, numerous affected dopamine neurons in animals injected with both parkin and alpha-synuclein were still going strong. The presence of parkin had protected the neurons from alpha-synuclein toxicity.

In addition, rats that had been injected with parkin showed an increase in Lewy body-type intracellular deposits. The researchers postulated that parkin might work to enhance cell survival by somehow transforming soluble toxic proteins into insoluble aggregates.

The findings constitute a significant step forward in understanding the molecular mechanisms behind the disease, says Lo Bianco. "We demonstrated for the first time the feasibility of the gene therapy approach in a genetic model of Parkinson’s disease."

Results of this research might lead to new treatments that could prevent the onset of Parkinson’s disease in genetically predisposed subjects and arrest the disease’s progression once it has been diagnosed, according to Aebischer. "These observations could translate into the clinic either through a direct gene therapy approach or through the identification of small drugs which enhance the expression of the endogenous parkin."

The next step, Lo Bianco notes, is to scale the system up to a primate model. The technique must be able to deliver genetic material to a sufficient number of cells to allow researchers to observe a beneficial effect. In addition, the therapy would have to be meticulously tested for possible side effects and long-term feasibility.

Mary Parlange | EurekAlert!
Further information:
http://www.epfl.ch

More articles from Life Sciences:

nachricht Rainbow colors reveal cell history: Uncovering β-cell heterogeneity
22.09.2017 | DFG-Forschungszentrum für Regenerative Therapien TU Dresden

nachricht The pyrenoid is a carbon-fixing liquid droplet
22.09.2017 | Max-Planck-Institut für Biochemie

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: The pyrenoid is a carbon-fixing liquid droplet

Plants and algae use the enzyme Rubisco to fix carbon dioxide, removing it from the atmosphere and converting it into biomass. Algae have figured out a way to increase the efficiency of carbon fixation. They gather most of their Rubisco into a ball-shaped microcompartment called the pyrenoid, which they flood with a high local concentration of carbon dioxide. A team of scientists at Princeton University, the Carnegie Institution for Science, Stanford University and the Max Plank Institute of Biochemistry have unravelled the mysteries of how the pyrenoid is assembled. These insights can help to engineer crops that remove more carbon dioxide from the atmosphere while producing more food.

A warming planet

Im Focus: Highly precise wiring in the Cerebral Cortex

Our brains house extremely complex neuronal circuits, whose detailed structures are still largely unknown. This is especially true for the so-called cerebral cortex of mammals, where among other things vision, thoughts or spatial orientation are being computed. Here the rules by which nerve cells are connected to each other are only partly understood. A team of scientists around Moritz Helmstaedter at the Frankfiurt Max Planck Institute for Brain Research and Helene Schmidt (Humboldt University in Berlin) have now discovered a surprisingly precise nerve cell connectivity pattern in the part of the cerebral cortex that is responsible for orienting the individual animal or human in space.

The researchers report online in Nature (Schmidt et al., 2017. Axonal synapse sorting in medial entorhinal cortex, DOI: 10.1038/nature24005) that synapses in...

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Rainbow colors reveal cell history: Uncovering β-cell heterogeneity

22.09.2017 | Life Sciences

Penn first in world to treat patient with new radiation technology

22.09.2017 | Medical Engineering

Calculating quietness

22.09.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>